TipRanks
Advertisement
Advertisement

DE:C43 Stock Latest News

Cosmo’s GI Genius AI System Boosts Adenoma Detection in Major VA Study
Company AnnouncementsCosmo’s GI Genius AI System Boosts Adenoma Detection in Major VA Study
17d ago
Cosmo Pharmaceuticals to Change SIX Ticker to CMHC, Aligning Brand With Health-Focused Strategy
PremiumCompany Announcements
Cosmo Pharmaceuticals to Change SIX Ticker to CMHC, Aligning Brand With Health-Focused Strategy
2M ago
Cosmo lifts recurring revenues and advances dermatology and GI pipelines
PremiumCompany Announcements
Cosmo lifts recurring revenues and advances dermatology and GI pipelines
3M ago
PremiumCompany Announcements
Cosmo sets date for 2026 half-year results and investor webcast
3M ago
PremiumCompany Announcements
Cosmo accelerates European rollout of first-in-class acne drug Winlevi
4M ago
PremiumCompany AnnouncementsCosmo and Glenmark roll out first-in-class acne drug Winlevi across key European markets
4M ago
Premium
Company Announcements
Cosmo completes Phase II recruitment for novel ulcerative colitis therapy
5M ago
Cosmo price target raised to CHF 160 from CHF 130 at H.C. Wainwright
Premium
The Fly
Cosmo price target raised to CHF 160 from CHF 130 at H.C. Wainwright
6M ago
PremiumCompany Announcements
Cosmo’s Clascoterone Delivers Strong 12‑Month Data in Male Hair Loss, Paving Way for 2027 Filings
6M ago
PremiumCompany Announcements
Cosmo Shareholders Approve All AGM Resolutions and EUR 2.10 Dividend
6M ago
PremiumCompany Announcements
Cosmo to Showcase Real-Time Medical AI Platforms at NVIDIA GTC 2026
7M ago
PremiumCompany Announcements
Cosmo Sets April General Meeting with Name Change and Payout on Agenda
7M ago
PremiumCompany AnnouncementsCosmo Pharmaceuticals Lifts Recurring Revenues, Boosts Dividend and Sets Growth Path to 2030
7M ago
Premium
Company Announcements
Cosmo teams with Dutch institutions to expand GI Genius AI into Barrett’s esophagus detection
7M ago
Premium
Company Announcements
Cosmo Pharmaceuticals to Court Investors at Major 2026 Healthcare Conferences
8M ago
PremiumCompany Announcements
Cosmo Pharmaceuticals Bolsters Institutional Base With Non‑Dilutive Treasury Share Placement
8M ago
Cosmo Pharmaceuticals Sets 9 March 2026 Webcast for 2025 Full-Year Results
PremiumCompany Announcements
Cosmo Pharmaceuticals Sets 9 March 2026 Webcast for 2025 Full-Year Results
8M ago
Cosmo Pharmaceuticals Enters Scale-Up Phase on Strong 2025 Results and AI, Dermatology Pipeline Momentum
PremiumCompany Announcements
Cosmo Pharmaceuticals Enters Scale-Up Phase on Strong 2025 Results and AI, Dermatology Pipeline Momentum
9M ago
Cosmo Pharmaceuticals’ Breezula: A Promising Breakthrough in Hair-Loss Treatment with Significant Market Potential
PremiumRatings
Cosmo Pharmaceuticals’ Breezula: A Promising Breakthrough in Hair-Loss Treatment with Significant Market Potential
10M ago
Cosmo Pharmaceuticals Unveils Breakthrough Results for Male Hair Loss Treatment
PremiumCompany AnnouncementsCosmo Pharmaceuticals Unveils Breakthrough Results for Male Hair Loss Treatment
10M ago
Cosmo Pharmaceuticals Expands Global Reach with Winlevi® Approval in Brazil
Premium
Company Announcements
Cosmo Pharmaceuticals Expands Global Reach with Winlevi® Approval in Brazil
11M ago
Cosmo Pharmaceuticals Advances in Sustainability with Enhanced ESG Rating and EcoVadis Recognition
Premium
Company Announcements
Cosmo Pharmaceuticals Advances in Sustainability with Enhanced ESG Rating and EcoVadis Recognition
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >